Every epilepsy gene, one test to know.
Standard epilepsy panels check a pre-selected list. Whole genome sequencing reads every gene linked to epilepsy — including SCN1A, SCN2A, STXBP1, CDKL5, KCNQ2 and 100+ more — plus pharmacogenomics data that can inform medication selection.
Standard genetic tests miss 99.98% of your DNA. Dante reads all of it — so nothing clinically relevant goes unseen.
A lifetime of clinical insights from a single test.
Get actionable genetic reports. User friendly portal organized by clinical area. 30X Genome Test. Full data ownership and privacy protection.
200+ Physician-Ready Reports
Comprehensive reporting across cardiology, oncology, rare disease, neurological conditions, and pharmacogenomics — designed to share directly with your specialist, and continually updated for life as science advances.
Secure Genome Manager
A HIPAA and GDPR-compliant portal with lifelong access to your complete clinical insights, new report releases as science advances, and specialist referral guidance.
30X Clinical Sequencing
Your entire genome sequenced at 30X coverage — the standard required for clinical-grade diagnosis. Every one of your 6.4 billion letters, read.
Full Data Ownership & Privacy
Unrestricted access to your BAM, VCF, and FASTQ files. Your genetic data belongs to you — export it to any independent specialist, at any time, forever.
Dante's secure data architecture was built across multiple, independent GDPR and HIPAA-compliant data protection layers. Your data is never shared with insurers, pharmaceutical companies, or research programs without your explicit consent. You can request deletion at any time.
Full data and privacy policy →The results doctors bring to their hardest cases.
"You save lives." — Dante Labs customer
Forty years of uncertainty. One test.
A patient had spent decades in the UK healthcare system without a diagnosis. Dante data, accepted by NHS clinical teams at Queen Elizabeth University Hospital Glasgow, identified Noonan Syndrome and a RUNX1 leukemia-associated variant that had gone undetected. After 40 years, they finally had an answer.
A complete read delivers a complete picture.
A patient came to Dante to investigate periodic paralysis. Reading the complete genome identified a concurrent hereditary cardiac finding — Brugada syndrome — that their doctor confirmed with an ECG. The result also explained a family member's unresolved cardiac history. One test. Every answer in it.
Sequenced in 2019. The data worked in 2021.
Jennifer sequenced her genome with Dante two years before her breast cancer diagnosis. When treatment began, Dante's pharmacogenomics data showed her prescribed chemotherapy would cause serious adverse effects based on her genetic profile. Her doctor selected an alternative — and she started effective treatment from day one.
Accredited by & published in
What you need to know before ordering.
All of them. Whole genome sequencing reads every gene linked to epilepsy — including SCN1A (Dravet syndrome), SCN2A, SCN8A, STXBP1, CDKL5, KCNQ2, PCDH19, DEPDC5, KCNT1, and 100+ more. Unlike standard epilepsy gene panels, whole genome sequencing covers every known pathway in a single test.
Whole genome sequencing results are typically delivered in 6–8 weeks once your sample arrives at the lab. You'll receive status updates by email at each step of the process.
Yes. Genetic findings can directly influence treatment decisions. For example, sodium channel blockers are contraindicated in SCN1A-related Dravet syndrome. Whole genome sequencing includes pharmacogenomics data that can help your neurologist select more effective medications and avoid those likely to cause adverse effects. Reports are physician-ready and classified using ACMG guidelines.
You own your data — you can download it, delete it, or anonymize it at any time. Dante does not sell your personal information or genomic data. All data is processed under HIPAA and GDPR compliance, in CLIA-certified, CAP-accredited laboratories holding ISO 15189 medical lab accreditation.
The answers that change what comes next.
One kit, sent to your home. Your entire genome sequenced at the clinical standard used for diagnostic decisions. 200+ physician-ready reports delivered to your Genome Manager in 6–8 weeks — permanent and updated as science advances. Your raw data — BAM, VCF, and FASTQ — downloadable at any time, forever yours.
Free global shipping · Results in 6–8 weeks
